Emergent BioSolutions
EBS
#8034
Rank
A$0.53 B
Marketcap
A$10.28
Share price
-0.55%
Change (1 day)
18.27%
Change (1 year)

Emergent BioSolutions (EBS) - Total assets

Total assets on the balance sheet as of March 2026 : A$1.87 Billion

According to Emergent BioSolutions 's latest financial reports the company's total assets are A$1.87 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Emergent BioSolutions - Total assets on balance sheet (from 2004 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$1.96 B-11.89%
2024-12-31A$2.23 B-16.51%
2023-12-31A$2.67 B-42.49%
2022-12-31A$4.65 B14.05%
2021-12-31A$4.07 B8.8%
2020-12-31A$3.74 B12.8%
2019-12-31A$3.32 B5.04%
2018-12-31A$3.16 B130.86%
2017-12-31A$1.37 B1.86%
2016-12-31A$1.34 B-5.5%
2015-12-31A$1.42 B24.16%
2014-12-31A$1.14 B63.27%
2013-12-31A$0.70 B29.39%
2012-12-31A$0.54 B1.8%
2011-12-31A$0.53 B8.28%
2010-12-31A$0.49 B28.37%
2009-12-31A$0.38 B-6.9%
2008-12-31A$0.41 B31.75%
2007-12-31A$0.31 B3.51%
2006-12-31A$0.30 B120.42%
2005-12-31A$0.13 B53.66%
2004-12-31A$89.23 M
2002-12-31A$40.45 M-18.8%
2001-12-31A$49.81 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
A$295.52 B 15,623.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$183.17 B 9,645.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$118.51 B 6,205.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
A$9.85 M-99.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
A$0.31 B-83.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$0.72 B-61.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$56.99 B 2,932.41%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel